CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16th Annual Meeting of the Association for Cancer Immunotherapy. Issue 12 (2nd December 2018)

• Record Type: Journal Article
• Authors: Beck, Jan; Birtel, Matthias; Reidenbach, Daniel; Salomon, Nadja; Diken, Mustafa
• Is Part Of: Human vaccines & immunotherapeutics. Volume 14:Issue 12(2018)
• Page Start: 2864
• Page End: 2873
• Publication Date: 2018-12-02
• Subjects: CIMT -- cancer immunotherapy -- tumor vaccination -- cellular therapy -- combination therapy -- tumor microenvironment -- checkpoint blockade -- personalized therapy; Vaccines -- Periodicals; 615.372
• DOI: 10.1080/21645515.2018.1504526
• Languages: English
• ISSNs: 2164-5515

Abstract

ABSTRACT: The 16th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe's largest meeting series of its kind, took place in Mainz, Germany from 15–17 May, 2018. Cutting-edge advancements in cancer immunotherapy were discussed among more than 700 scientists under the motto "Pushing Frontiers in Cancer Immunotherapy". This meeting report is a summary of some of the CIMT 2018 highlights.